Axial Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Axial Therapeutics's estimated annual revenue is currently $4.3M per year.
- Axial Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Axial Therapeutics has 28 Employees.
- Axial Therapeutics grew their employee count by -24% last year.
Axial Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | SVP and Head R&D, | Reveal Email/Phone |
3 | Controller | Reveal Email/Phone |
4 | VP, Finance | Reveal Email/Phone |
5 | Director, Preclinical Development and Operations | Reveal Email/Phone |
6 | Sr. Director, Head Clinical Operations | Reveal Email/Phone |
7 | Chief Financial Officer | Reveal Email/Phone |
8 | Senior Director, Chemistry | Reveal Email/Phone |
9 | Co-founder, CEO and Director | Reveal Email/Phone |
10 | Director Business Development | Reveal Email/Phone |
Axial Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Axial Therapeutics?
Axial Therapeuticsâ„¢ is a clinical-stage biopharmaceutical company focused on the discovery and development of gut-restricted, small molecule therapeutics for central nervous system (CNS) disorders. The company is leveraging its expertise in the gut-brain axis and its unique drug development platform to advance novel therapies that have the potential to transform the treatment paradigm in neurodegenerative diseases.
keywords:N/A
N/A
Total Funding
28
Number of Employees
$4.3M
Revenue (est)
-24%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Axial Therapeutics News
Axial Therapeutics is a clinical-stage biopharmaceutical company dedicated to improving the lives of people with neurological disorders and...
Respira Therapeutics Announces First Patient Dosed in Phase 2b ... doses administered via an Axial Oscillating Sphere dry powder inhaler.
Other Companies in Waltham
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4.4M | 28 | 8% | N/A |
#2 | $5.3M | 28 | 0% | N/A |
#3 | $2.8M | 28 | -3% | N/A |
#4 | $5.7M | 28 | 8% | N/A |
#5 | $5.3M | 28 | 0% | N/A |